Home  >  Companies  >  Pathos Pathos Follow AI-enabled clinical-stage biotech building a platform that uses multimodal oncology patient data and machine learning to identify patients, design and run more predictive clinical trials Valuation $3.00B 2026 Funding $467.00M 2026 View PDF Embed PDF Details Headquarters Chicago, United States CEO Iker Huerga Website pathos.com Milestones FOUNDING YEAR 2022 Pathos Overview Metrics News Unlock Pathos data Sign up for data access